QT Holdings Corp.

BEVERLY, MA · Founded 2012 · CIK 0001605603 · Biotech · Acquired

Affinity chromatographic cell sorting system using dissolvable hydrogel microbeads for magnetic-particle-free cell purification

Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.8M
2 Form D · Sep 2015
133 months since last filing
Contracts
—
No federal contracts on record
Patents
8
3 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$475,000
Private capital raisedForm D · SEC$3,285,938
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2169VISIONARY PHARMACEUTICALS, INC.——
2170Excision BioTherapeutics Inc.—$71M
2171Context Therapeutics—$100M
2172QT Holdings Corp.—$3.8M
2173LOKI THERAPEUTICS, INC——
2174Aruvant Sciences——
2175Arena Therapeutics OpCo, Inc.—$600K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Sean KevlahanExecutive Officer
  • Sean Kevlahan, Ph.D.Director · Executive Officer
  • William MckenzieDirector
  • Rebecca MenapaceDirector
  • Shashi MurthyDirector

Patents

USPTO · 3 granted of 8

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.